Home
About
Overview
Sharing Data
ORCID
Help
History (28)
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer.
Neoplasm Micrometastasis
Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
Dudzik, Lorna
Review of paclitaxel/carboplatin in advanced non-small cell lung cancer.
See All 28 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Review of paclitaxel/carboplatin in advanced non-small cell lung cancer.
Review of paclitaxel/carboplatin in advanced non-small cell lung cancer. Semin Oncol. 1999 Feb; 26(1 Suppl 2):55-9.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms
Paclitaxel